<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta2GPI) is an important target antigen for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) and thus beta2GPI polymorphisms may influence aPL production and the development of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We have studied the relationship between the Val247Leu and Trp316Ser beta2GPI polymorphisms and the aPL status of 230 patients referred for aPL screening </plain></SENT>
<SENT sid="2" pm="."><plain>Sixty-one (26.5%) had persistent aPL [anticardiolipin antibodies (IgG and/or IgM), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and/or IgG anti-beta2GPI antibodies] </plain></SENT>
<SENT sid="3" pm="."><plain>A comparison of the genotypic and allelic frequencies of these two polymorphisms between the Caucasian patient population and an ethnic-matched <z:mpath ids='MPATH_458'>normal</z:mpath> control group (n = 308) showed no significant differences between aPL-positive patients, aPL-negative patients and the <z:mpath ids='MPATH_458'>normal</z:mpath> control group </plain></SENT>
<SENT sid="4" pm="."><plain>This suggests that the Val or Leu allele at position 247 and the Trp or Ser allele at position 316 of beta2GPI do not play a role in the production of aPL </plain></SENT>
<SENT sid="5" pm="."><plain>There was a significantly decreased prevalence of the Ser316 allele in aPL-negative women (n = 98) when compared with female <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects (n = 249) [0.020 [95% confidence interval (CI) 0.00-0.04]vs 0.060 (95% CI 0.04-0.08), P = 0.0286] </plain></SENT>
<SENT sid="6" pm="."><plain>Subgroup analysis showed no significant difference between female patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> and female <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, the Ser316 allele may protect women from developing <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">pregnancy complications</z:e> by influencing an <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> function of beta2GPI via a mechanism distinct from aPL production </plain></SENT>
</text></document>